BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 294 filers reported holding BIONTECH SE in Q1 2022. The put-call ratio across all filers is 1.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $205,642 | -11.3% | 2,559 | +1.8% | 0.00% | – |
Q1 2024 | $231,825 | -15.0% | 2,513 | -2.7% | 0.00% | – |
Q4 2023 | $272,610 | +198.7% | 2,583 | +207.5% | 0.00% | – |
Q3 2023 | $91,258 | +43.3% | 840 | +42.4% | 0.00% | – |
Q2 2023 | $63,679 | -17.8% | 590 | -5.1% | 0.00% | – |
Q1 2023 | $77,495 | -18.6% | 622 | -1.9% | 0.00% | – |
Q4 2022 | $95,254 | -36.1% | 634 | -42.7% | 0.00% | – |
Q3 2022 | $149,000 | -10.2% | 1,106 | -0.9% | 0.00% | – |
Q2 2022 | $166,000 | +3.8% | 1,116 | +19.2% | 0.00% | – |
Q1 2022 | $160,000 | -76.0% | 936 | -63.8% | 0.00% | -100.0% |
Q4 2021 | $666,000 | +11.7% | 2,584 | +18.3% | 0.00% | 0.0% |
Q3 2021 | $596,000 | +297.3% | 2,184 | +226.0% | 0.00% | – |
Q2 2021 | $150,000 | +89.9% | 670 | -6.9% | 0.00% | – |
Q1 2021 | $79,000 | -44.8% | 720 | -59.1% | 0.00% | – |
Q4 2020 | $143,000 | +297.2% | 1,760 | +238.5% | 0.00% | – |
Q3 2020 | $36,000 | +2.9% | 520 | 0.0% | 0.00% | – |
Q2 2020 | $35,000 | – | 520 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 148,674 | $11,947,443 | 19.99% |
Quinn Opportunity Partners LLC | 683,287 | $54,908,943 | 6.24% |
Krensavage Asset Management, LLC | 132,293 | $10,631 | 4.88% |
Crocodile Capital Partners GmbH | 29,586 | $2,377,531 | 3.78% |
ALTRINSIC GLOBAL ADVISORS LLC | 676,219 | $54,340,958 | 2.42% |
FLOSSBACH VON STORCH AG | 4,379,483 | $351,935,254 | 1.48% |
Systrade AG | 10,000 | $803,600 | 1.38% |
HARDING LOEVNER LP | 2,926,761 | $235,224,417 | 1.30% |
CenterBook Partners LP | 206,234 | $16,572,964 | 1.03% |
SECTORAL ASSET MANAGEMENT INC | 27,265 | $2,191,015 | 0.89% |